Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Stanford researchers are developing a faster way to match each ulcerative colitis patient with the treatment that will work best for them.
Researchers are using a new artificial intelligence-based program to help identify genes that underly diseases.
Researchers are searching large, diverse genetic databases to better understand the roots of diabetes in diverse populations.
Tiny fish evolve rapidly and predictably by diving into a 'genetic toolbox' shared with other organisms including Darwin's finches.
Stanford Medicine researchers and others discovered 13 genetic signatures that are closely linked to an increased risk for severe COVID-19.
Using racial classifications to guide care could result in poorer health outcomes for non-white patients, medical professionals say.
Euan Ashley, professor of medicine and genetics, tells the stories of his patients with rare or mystery diseases through his new book, The Genome Odyssey.
Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.
In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.
Stanford scientists have found two genes associated with concussion. Screening football players and military might identify those at higher risk.
A Stanford researcher talks about navigating the uncertainty of making medical decisions for her 5-year-old son with an undiagnosed genetic disorder.
Abdominal adhesions frequently occur after abdominal surgery. Stanford researchers prevented their formation in mice by blocking a molecular pathway.
A Stanford-led study finds that remnants of an ancient viral infection may be the reason humans and other primates evolved to have larger hearts and bodies.
Stanford researchers and colleagues have invented a genetic safety mechanism that can deactivate transplanted cells if they change in a problematic way.
The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.